In collaboration with University of Wisconsin physician-scientists, Thomson has subsequently demonstrated the developmental potential of human embryonic stem cells in lineage-specific differentiation, such as blood, trophoblast, neural tissue and heart (James). Currently his focus is directed on understanding how embryonic stem cells can "form any cell in the body, how an ES cell chooses between self-renewal and the initial decision to differentiate, and how a differentiated cell with limited developmental potential can be reprogrammed to a pluripotent cell" (James).
Also of concern are issues of privacy and confidentiality. A woman donating her embryo or fetus to research may fear that the DNA that could exist indefinitely in these sources might one day be traced back to her, thereby revealing her identity and her association with the fertility clinic (Young). For example, if the fetus is obtained via an abortion, whether it can be genetically traced back to the donor plays a critical role in a woman's decision of whether or not to donate to research (Young). She might fear that the results of genetic tests could somehow be traced to her, and that such information might find its way to her employer or insurer (Young). The issues of privacy and confidentiality can create quite a dilemma. For example, doctors much now consider a woman's right 'not to know' any diseases or illnesses she might potentially develop or pass on to her children. This problem can be solved by researchers and doctors obtaining a donor's informed consent and "taking particular care to inform the donor of any potential privacy risks" (Young). Yet, informed consent comes with it own set ethical problems. For example, some lawmakers suggest that consent be obtained from at least three separate sources: the mother, father and any recipient of stem cell products (Young). Others debate over the definition of 'informed' and how much information should be given to either party.
In August 2001, President Bush decided to allow funding for research on stem cell lines that were already in existence as of August 9, 2001, and required that lines must have been derived "with the informed consent of the donors; from excess embryos created solely for reproductive purposes; and without any financial inducements to the donors" (Stevens). In other words, federal government will fund research using existing qualified embryonic stem cell lines, but will not fund the creation of new stem cell lines or any research performed on those lines (Stevens). Furthermore, the federal government has also agreed to fund research on "umbilical cord, placenta,...
Bush's policy does not affect privately funded embryonic stem cell research, thus private research is exempt from Bush's restrictions. Two issues of concern arise from Bush's policy. One concern is that private funding may not be sufficient, since biotechnology research requires more capital than other entrepreneurial industries (Stevens). Another concern is that under Bush's policy, "embryonic stem cell research in the private sector is not subject to federal monitoring or ethical requirements," which may place the U.S. In a disparate position internationally (Stevens).
In January 2001, Great Britain became the first nation to pass a law allowing limited human cloning for the purpose of cloning stem cells from human embryos, however human cloning remains illegal and any embryo involved in stem cell research cannot be used after fourteen days (Stevens). Australia bans human cloning but allows human stem cell cloning for medical research, while Israel has no law regulating stem cell research (Stevens). As of 2000, China allows embryonic stem cell research for treatment and prevention of disease as long as such research is rational and effectively monitored, and in 2001, Japan approved strict guidelines which states that "embryonic cells used in research would be taken only from those made for fertility treatment that would otherwise be discarded," and like the U.S., Japan has also placed a ban on human cloning research (Stevens). Canadian scientists are allowed to use excess embryos from fertility clinics with donor consent, but are prohibited from creating embryos solely for research purposes, while German law restricts laboratory use of embryos to in vitro fertilization only (Stevens).
Stem cell research has the potential of developing treatment for some of the most serious medical conditions, such as cancer, spinal cord injuries, and birth defects. While some oppose any type of stem cell research, others oppose only the use of embryonic stem cells but support stem cells derived from adults (such as from bone marrow), from umbilical cords, and from animals. Experts emphasize the need for adequate federal and international uniformity concerning the regulation of embryonic stem cell research to avoid potential abuse.
James A. Thomson." University of Wisconsin. Retrieved November 15, 2006 at http://ink.primate.wisc.edu/~thomson/jamie.html
Seely, Ron. "Stem Cell Work Sets Him Apart Pioneering Research Puts UW-Madison
Scientist James Thomson in the National Spotlight." Wisconsin State Journal (Madison, WI). December 30, 2001. Retrieved November 15, 2006 from HighBeam Research Library.
Stem Cell Information." The National Institutes of Health. Retrieved November 15, 2006 from: http://stemcells.nih.gov/info/basics/basics1.asp
Stevens, Denise. "Embryonic stem cell research: will President Bush's limitation on federal funding put the United States at a disadvantage? A comparison between U.S. And international law." Houston Journal of International Law. March 22, 2003. Retrieved November 15, 2006 from HighBeam Research Library.
Young, Cynthia Donley. "A comparative look at the U.S. And British approaches to stem cell research." Albany Law Review. March 22, 2002. Retrieved November 15, 2006 from HighBeam Research…
A pre-embryo is the fertilized cell that has not yet been planted into the human host. Once the pre-embryo is implanted into the female host, it is assumed that it will grow and develop into a human being. The pre-embryo is not the same as the embryo, it is simply the raw material. A national bioethics committee has been assigned the duty of exploring these issues and making recommendations that
This is why it came as no surprise to the rest of the country when Proposition 71 was passed, in direct opposition to the policies of the Bush administration. Even California's governor, a Republican and Bush supporter, sided with Californians on the stem cell issue. The promise of freedom to research as they see fit and the funding to do so will likely draw more scientists to California, should
Stem Cell Research Should Have More Government Funding The topic argument "Stem cell research government funding." For paper, construct argument defending a claim policy. Remember argument based a claim policy, writer seeks solve a problem establish a problem exists, part argument entail claims fact Stem cell research should have more government funding A stem cell can be defined as type of cell that can be found in many body tissues. Stem cells can
but, Cuomo continued, Bush's position "…remains a minority view" (Hurlbut, 822). Christine Todd Whitman, who served Bush as administrator of the Environmental Protection Agency in Bush's first term (she served from January 2001 to May 2003), and was the first female governor of New Jersey, supported embryonic stem cell research. Whitman noted in her book that right after Bush was re-elected in 2004, Christian conservative organizer Phil Burress was heard
At this point it should be clear that there are no good reasons to oppose the federal funding of embryonic stem cell research and only good reasons for supporting. Opposition to the federal funding of embryonic stem cell research can only be justified by an appeal to unreasonable and arbitrary moral standards based not on logic, reason, or concern for human well-being, but rather on the dictates of outdated and
Stem Cell Research The Legal Argument and Analysis for Stem Cell Research Stem cell research is a new field of research that brings many ethical issues and considerations in which U.S. regulations have been mostly hostile while around the world, the response toward the research has been positive. What is the legal culture in which the U.S. finds itself regarding stem cell research? What are the ethical considerations involving our participation in